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Background: Patients with type 2 diabetes mellitus (T2DM) who participate in diabetes management programs
have been shown to have better glycemic control and slower disease progression, although program participation
remains low. In the USA, increasing participation in diabetes management support programs may also directly
impact provider reimbursement, as payments are increasingly based on patient-centered measures. However, little
is known about factors that may enhance patient participation. This study aimed at further understanding what is
important in diabetes management support from the patients’ perspective and at assessing the utilization of
various types of diabetes-management programs.
Methods: A two-phase mixed-methods study was conducted of adult US members of PatientsLikeMe®, an online
research network of patients. Phase 1 comprised qualitative interviews with 10 individuals to inform the online
survey’s contents, aided by literature review. During phase 2, this online survey was completed by 294 participants
who reported on their diabetes goals and preferences for T2DM self-management support programs.
Results: The majority of the respondents were not participating in any program (65 %), but most had goals of
improving diet (77 %), weight loss (71 %), and achieving stable blood glucose levels (71 %). Among those currently
participating in programs, clinic, hospital-based, or other health-care professional programs were the most commonly
used (51 %). The most preferred type of support was diet/weight-loss support (62 %), while doctors or nurses (61 %)
and dietitians (55 %) were the most preferred sources of diabetes support.
Conclusions: The low participation in diabetes self-management programs revealed in this study underscores the
need for strategies to improve patient engagement. The results revealed support types and formats that patients with
T2DM prefer and need. These findings may help improve patient engagement by guiding the future design of more
effective diabetes management support programs.
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Type 2 diabetes mellitus (T2DM) affects approximately
29.1 million individuals in the USA and is primarily a
self-managed disease in which self-care behaviors
(e.g., following a healthy diet, being physically active,
and taking prescribed medications) play a crucial role. It
has been shown that engaging patients to take part in their
own therapy can lead to quantifiable improvements in
health-care quality and safety, particularly for chronic dis-
eases such as T2DM [1, 2]. Patient engagement is increas-
ingly being seen as a crucial component in the provision
of high-quality health-care [3]. Joint guidelines published
by the American Diabetes Association (ADA) and the
European Association for the Study of Diabetes (EASD)
recommend a patient-centered approach for the treatment
of T2DM, in which patient preferences, needs, and values
should be taken into consideration [4]. Furthermore, the
Patient Protection and Affordable Care Act (PPACA) en-
courages patient-centered medical decision-making and
greater patient engagement in the management of their
own care [5]. Within the context of the PPACA, patient
engagement is becoming an economic imperative as the
Center for Medicare & Medicaid Services is increasingly
shifting its reimbursement system to base payments upon
quality measures surrounding patient outcomes.
As self-care behaviors play a crucial role in T2DM man-
agement, a better understanding is needed of the factors
that influence patient engagement. A recent study found
that a complex set of subjective experiential dimensions
(cognitive, behavioral, and emotional) were involved in
patient engagement, and it underscored the need to
develop assessment tools to elucidate the nature of
patient engagement from the viewpoint of the individ-
ual patient experience [6]. Perhaps unsurprisingly, it
has been demonstrated that patients are more likely to
adhere to treatment regimens that offer benefit from
their own perspective [7, 8].
A range of diabetes management programs exists to
help patients with T2DM monitor and manage their
condition on a day-to-day basis and improve their out-
comes. Although many diabetes-management programs
have been shown to be beneficial for patients, formal pro-
gram participation remains low [9, 10]. Little is known
about what drives patient preferences for certain diabetes
management programs above others and if patient charac-
teristics play a role. As patient preferences, needs, and
values increasingly become drivers of individualized
treatment plans and of patient engagement, a clear
understanding of the components of these elements could
facilitate the design of better disease management pro-
grams that may result in improved patient participation,
engagement, and adherence.
With the aim of improving future program implementa-
tion, Pimouguet et al. performed a meta-regression analysisof data from 41 randomized controlled trials to determine
which elements of diabetes management programs are the
most effective [11]. Two approaches emerged that were
particularly effective: the ability for disease managers to
modify the treatment of patients without prior physician
approval, and a high frequency of patient contact. The
authors concluded that the disease management approach
resulted in significant improvements in glycemic control
compared with conventional care [11].
The current study aimed to quantify and assess the
utilization of various types of diabetes management
programs among a real-world sample of patients with
T2DM, in order to elucidate patient preferences for
diabetes management and support. Following the Patient-
Centered Research Outcomes Institute (PCORI) guide-
lines, patient-reported preferences and perspectives on
support programming were first identified from a targeted
subsample representing the T2DM patient population.
These findings were then used to design and shape the
study content [12].
Methods
The study was conducted through PatientsLikeMe®
(PLM) [13], an online platform comprising many disease
communities where patients with life-changing medical
conditions are able to find other patients like themselves,
learn more about their condition, and share information
about their outcomes. PLM has over 10,000 registered
members with T2DM and approximately 8000 reporting
T2DM as their primary condition, many of whom also re-
port significant comorbidities. Patients with T2DM joining
the website are asked to share information about their
disease through custom questionnaires that populate
their profile.
Following institutional review-board approval, a
mixed-methods research process, including a comprehen-
sive literature review, qualitative one-on-one patient inter-
views (January 2014), and a quantitative survey (April–July
2014), was used to comprehensively assess patient prefer-
ences regarding self-management support and diabetes
management programs. Informed consent was obtained
from all participants.
An extensive literature review of program support and
assistance for patients with T2DM was first conducted
to identify areas of evidentiary gaps for further exploration
in the qualitative patient interviews. The areas identified
included understanding the context in which patients
make decisions about support for their diabetes (family
structure, sources of assistance available), what the most
important symptoms and problems requiring management
are, who gives what kind of support, and which support
programs patients may have tried in the past. Patients’ de-
scriptions of their own goals, the relative importance of
different kinds of support and support sources, and their
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survey, which was subsequently administered to a larger
group of patients with T2DM.
Qualitative interview process
A list was generated of PLM website users who reported
T2DM in their patient profiles, had multiple log-in ses-
sions including activity in diabetes forums, and were ac-
tively participating in discussions. Of the identified
individuals, 44 were contacted, mainly by private message
(using PLM email), and invited to participate in 1-h quali-
tative telephone interviews. Once 10 of the invitees had
responded positively, no further invitations were sent out.
The respondents, half of whom were female, had a
mean age of 57.5 years (range 34–78). Overall, 60.0 %
(n = 6) were non-Hispanic white, and educational levels
ranged from high-school diplomas to Master’s degrees.
Patients’ experiences with controlling blood glucose
levels and managing symptoms and treatment regimens,
and types of programs and support systems used were
the key topics that guided the interviews. For a full de-
scription of the qualitative interview process, please see
Additional file 1.
Qualitative interview findings
Respondents reported common comorbidities including
hypertension, hypercholesterolemia, depressive disorders,
and chronic obstructive pulmonary disease. The majority
perceived their blood glucose levels to be under control,
although they were concerned about their weight and
activity levels. Of the T2DM support systems/programs
that respondents reported having participated in, most
were one-time programs in which all follow-up was initi-
ated by a nurse, not by the patient themselves.
Respondents reported that much self-education was per-
formed through reading both online and printed materials.
Websites commonly consulted included those of the ADA,
PLM, insurance companies, and medical-supplies compan-
ies, as well as general medical websites. This was in agree-
ment with information given by respondents that they
preferred their materials to be from a ‘serious’ source and
to be accessible at the patient’s own convenience. A few
female respondents strongly favored participation in small
groups for encouragement, sharing, and friendship; how-
ever, none actually belonged to such a group.
When questioned about their expectations/hopes for
management programs, a range of responses were given,
including the desire to not have diabetes or to slow or
stop disease progression, to decrease or stop medication
use, and to avoid complications (e.g., neuropathy, foot ul-
cers/amputation, heart disease, vision problems, peripheral
artery disease). Respondents reported being motivated by
wanting to keep learning and to avoid the negative conse-
quences of their disease. They reported being discouragedfrom participating in programs because of the difficulty in
navigating certain health-care systems and from continued
participation due to repetition of material.
When asked from whom they received help in the
management of their condition and what form that help
took, responses included spouse, adult children, other
family members (who often also had diabetes themselves),
and online friends. Support and encouragement from
health-care professionals (HCPs) was mostly related to
diet and medication; additional encouragement and praise
on dietary decisions and/or weight loss were desired.
‘Being accountable to someone else’ was considered to
be a positive thing.
Overall, and importantly, respondents perceived ‘pro-
grams’ as consisting of short-term education by HCPs,
whereas ‘support’ was regarded as daily interactions with
friends and family.
Concepts and themes regarding diabetes management
and support strategies that emerged from the patients’
descriptions informed the creation of quantitative survey
questions and response options that reflected the patients’
experiences. These themes included, but were not limited
to, weight loss as an area of concern and as a goal for
T2DM programming; the importance of modes of support,
such as printed materials, in T2DM education; sources
of support, such as spouses, partners, family, and
friends, in effectively managing T2DM; and how per-
sonal expectations/hopes for T2DM can align with
goals of T2DM support programming.
Quantitative survey process
Survey development
Based on the results from the qualitative interviews and
literature review, a survey consisting of a maximum of
90 questions (accounting for branching and variable
questions asked only in response to specific answers
to prior questions) and including both closed (Likert-scale,
multiple-choice, matrix, and numerical) and open (free-
form text) response formats was created [see Additional
file 2]. Patient-reported interview data were used to frame
and develop questions for use in the quantitative survey.
For example, descriptions of diabetes support programs
obtained in response to questions from Part 3 of the quali-
tative survey [see Additional file 1] were used to construct
the support program types mentioned in Sections IV, V,
and VI of the quantitative survey [see Additional file 2]
as well as to provide lists of commonly mentioned
response options.
In the survey, respondents were asked to confirm the
demographic information previously collected from their
profiles by completing a basic demographics panel prior
to addressing the main survey questions. Demographic
data concerning sex, date of birth, ethnicity, race, educa-
tional level, and health-insurance type were collected.
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re-collected from respondents at this point as well. In
addition to the demographic covariates, the main survey
was composed of seven domains which were framed
from the patient perspective:
(1)Overall quality of life – to understand all areas of
health of the patient
(2)Diabetes goals – to focus on what patients want
from their disease control
(3)Current and past programs – to assess program
participation and preferences/dislikes
(4)Preferences for self-support – to understand the
types, sources, and formats of support that patients
want when managing their diabetes
(5)Support network – to give an insight into who (or
what) comprises the patient’s current support network
(6)Treatments and complications – to provide data on
what patients have experienced
(7)Comorbidities – to provide data on patient-identified
additional conditions
An appended sub-survey queried patients on the follow-
ing: their satisfaction with their health-care; difficulties
managing symptoms; glycated hemoglobin A1c (A1C), low-
density lipoprotein, and blood pressure measurements; use
of oral steroids; weight-loss goals; health literacy; and self-
reported treatment adherence.
Branching within the survey was incorporated to address
program characteristics, information covered, program
length, and outcomes for respondents who participated in a
program. Approximately 20 of the 90 questions were in
free-form text format, which queried survey respondents
on what ‘other’ types of programs, information, or diabetes
support they participated in, wanted, or preferred.
Study population
The online survey was fielded during April to July 2014
to active PLM participants reporting T2DM as a condi-
tion on their profile, who also reported residing in the
USA or did not specify their location and who were
aged ≥ 18 years. The initial pool of invitations was lim-
ited to the most active patients (those who had logged in
to the site in the past 90 days). A second pool of invita-
tions was created for participants who had lower activity
(at least one log-in during the past year).
Survey fielding
Patients fulfilling study inclusion criteria were emailed
an invitation to participate in a custom survey. The survey
fielding was conducted in two waves, a pilot survey and a
full survey. The pilot survey was fielded to assess the in-
terpretability of questions by a sample of 100 members
with T2DM, and remained open for 2 weeks. The fullsurvey was fielded to the larger T2DM population and
remained open for a period of approximately 12 weeks.
For both the pilot and full surveys, the invitation to par-
ticipate appeared as a private message when a T2DM
patient logged in to the site. The invitation included a link
directing the patient to where the survey could be com-
pleted online. Users who did not complete surveys
within 3 days were sent an email reminder to partici-
pate in the survey.
Statistical analyses
The population for the main analysis consisted of all
confirmed US-based patient respondents who fulfilled
the inclusion criteria. As there were no changes to the
survey, responses obtained during the pilot survey were
merged with full survey results prior to data analysis. To
provide additional context on the PLM T2DM community,
survey respondents were compared with nonrespondents
with respect to their demographic characteristics, any listed
(additional) conditions, and their PLM website participation
as a preface to the main analyses. Before analyzing survey
results, available profile data (such as location, primary
condition, and zip code) were matched to survey re-
sponses by a unique user ID number. Zip codes were then
grouped according to area type (urban, suburban, rural)
using US Census data.
Descriptive statistics were used to describe patient
characteristics by demographic covariates of interest, and
summary statistics were used to tabulate frequencies and
relative percents, such as patient use of different self-
management support systems. χ2 statistics were used for
categorical variables, and two-sample t-tests were used to
compare groups for continuous covariates. Trend tests
were used to test two-category predictor variables on
ordinal-ordered outcomes, such as program participation
and satisfaction with one’s health-care. Agreement be-
tween binary paired variables, such as past and current
program participation, was assessed with the kappa
statistic. Only P-values of ≤ 0.05 were reported, and all
tests were two-tailed. Free-text or ‘other’ text response
options were analyzed by summarizing key concepts
by ‘theme’ and enumerating the mention of each theme.
Quantitative analyses were conducted with SAS, Version
9.4 (Cary, NC, USA).
Ethics, consent, and permissions
This study was approved by the Western Institutional
Review Board on December 31, 2013. Materials sent to
study participants such as invitation messages, together
with the interview guide, research information, and
participant consent were reviewed and approved by the
Review Board. Using online means, the nature of the
study was explained to potential participants prior to
participation, and informed consent was obtained for
Table 1 Demographic characteristics of the PLM T2DM population
Characteristic PLM sample (N = 294)
Age, mean (±SD), years 56.5 (±10.6)
Sex, n (%)
Male 105 (35.7 %)
Female 189 (64.3 %)
Race, n (%)
White 245 (83.9 %)
Black/African-American 21 (7.2 %)
Mixed race 10 (3.4 %)
Asian 5 (1.7 %)
Native American 1 (1.0 %)
Prefer not to say 10 (3.4 %)
Ethnicity, n (%)
Hispanic 10 (3.4 %)
Self-reporteda A1C, mean (±SD), % 7.04 (±1.6)
Educational level, n (%)
High-school degree or less 51 (17.8 %)
Some college 129 (45.1 %)
College graduate 65 (22.7 %)
Postgraduate education 41 (14.3 %)
A1C glycated hemoglobin A1c, SD standard deviation;
aN = 146
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form. Verbal consent was obtained for the audio record-




A survey participant flow diagram is shown in Fig. 1. A
total of 5665 PLM users who fulfilled the inclusion criteria
were sent the survey invitation. Responses (including partial
responses) were received from 294 confirmed US-based
invitees, and these formed the total sample for analysis.
Survey sample characteristics
Table 1 shows the demographic characteristics of the
PLM sample of adults with T2DM; the survey sample
was mostly white (83.9 %) and female (64.3 %), with a
mean age of 56.5 years.
The demographic characteristics of respondents versus
nonrespondents were first compared between the samples,
and the populations were found to be generally similar.
The majority of survey respondents and nonrespondents
were white (83.9 and 82.3 %, respectively), aged 56 years
on average (56.5 vs 55.5 years), and had some college edu-
cation (45.1 % vs 46.7 %). Significantly more respondents
than nonrespondents were insured via Medicare (35.9 %
vs 25.3 %, respectively; P < 0.01) and slightly more were
male (35.7 % vs 28.6 %; P = 0.03).
Survey respondents were assessed on their general
health, quality of life, and diabetes goals. The mean A1C
level of respondents (n = 146) was 7.04 %, showing that
glycemic control was good in almost 50 % of patients
who provided information. Overall, most respondentsFig. 1 Flow diagram of study participants. aParticipation rate = 37.1 %;
bCompletion rate = 30.4 %(65.2 %) rated their general health to be fair (33.8 %) or
good (31.4 %), and about half reported little-to-no dis-
tress in feeling overwhelmed by the demands of living
with diabetes (56.1 %) or feeling that they were often
failing with their diabetes regimen (50.2 %). The majority
of respondents (88 %) reported having ≥ 1 key comorbid
condition in addition to their T2DM. Overweight/obes-
ity (72.8 %), high blood pressure (64.3 %), high blood
cholesterol (63.6 %), and depressive disorders (53.1 %)
were the most commonly selected comorbid conditions.
Diabetes program utilization
Figure 2 shows the current program utilization by survey
respondents. Among the 285 respondents, nearly two-
thirds reported not currently participating in any program
or not having participated in any diabetes management
programs in the past. Of those currently participating in a
program, nearly two-thirds reported a positive change in
their diabetes (Table 2) and more than 18 % believed that
they were ‘doing much better.’
A significant association was found when comparing
past program participation to current program participa-
tion (χ2 = 13.04; P < 0.01). While the majority of respon-
dents who had not participated in programs in the past
were currently not participating in a program (73.9 %),
those who currently participate in programs were more
likely to have participated in a past program than those















or other HCP program
Frequency,    (%)
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n
Fig. 2 Program utilization among survey respondents currently participating in a form of supporta (n = 101). HCP, health-care professional.
aRespondents could have participated in more than one program
Table 2 Change in diabetes as a result of program participation
Question/statement Frequency (N = 91)
Have you noticed any change in your diabetes as a result of
participating in a program? n (%)
I am doing much better 17 (18.7 %)
I am doing a little better 42 (46.2 %)
I haven’t noticed any change in my diabetes 28 (30.8 %)
I am doing a little worse 4 (4.4 %)
Change in diabetes as a result of program participation n (%)
No change or doing worse














Doing a little or a lot better














How likely would you be to repeat this program in the future? n (%)
Extremely likely 13 (14.3 %)
Likely 29 (31.9 %)
Neutral 30 (33.0 %)
Unlikely 6 (6.6 %)
Extremely unlikely 13 (14.3 %)
HCP health-care professional
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less than half (48 %) of past program participants go on
to participate in a program again is reflected in the
kappa statistic of 0.22, indicating only fair agreement
between past and present program participation.
Among those currently participating in programs
(n = 101), respondents most commonly participated in
clinic, hospital-based, or other HCP programs (n = 51;
50.5 %), followed by online programs (n = 25; 24.8 %) and
‘other’ personalized programs (n = 22; 21.8 %) that they
designed/implemented on their own (Fig. 2). ‘Other’ pro-
grams mentioned by participants included specific diet
plans, combination diet/exercise/lifestyle approaches, indi-
vidualized daily planning, online programs and online
counseling, and bariatric bypass surgery.
Figure 3 shows the overall level of satisfaction of re-
spondents with their health-care team in the past year
according to current program participation. When ques-
tioned about their overall level of satisfaction with their
health-care team in the past year, respondents who were
currently participating in a program had significantly
greater satisfaction with their health-care team during the
past year than those who were not participating (Z = −2.28;
P = 0.002 for trend). Dissatisfaction likewise appeared to be
lower among current program participants.Patient preferences for diabetes self-management programs
and support
Figure 4 gives an overview of the types of support preferred
by survey respondents (N = 294). Overall, diet/weight loss
support was the most preferred type of support,
followed by more supportive/engaged doctors and
other HCPs. Doctors or nurses (n = 179; 60.9 %) and di-
etitians (n = 162; 55.1 %) were the most preferred
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Fig. 3 Overall satisfaction with health-care team in the past year by current program participationa. a Z = −2.28; P = 0.0022
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were ‘eat a better diet/manage food’ (n = 226, 76.9 %),
‘lose weight’ (n = 210, 71.4 %), ‘keep blood sugar levels
stable’ (n = 210, 71.4 %), and ‘keep A1C value at a certain
level’ (n = 199, 67.7 %), followed by ‘do regular physical
activity’ (n = 153, 52.0 %) and ‘manage stress better’ (n =
119, 40.5 %). Only 20 respondents reported having set
no goals for themselves at all (6.8 %).
When queried about the formats of support information
they most preferred, respondents most frequently pre-
ferred online information, followed by print materials and
verbal information from a doctor (Fig. 6). Of the 184 re-
spondents who reported receiving diabetes support from
other people, 76.6 % received support exclusively from
doctors or nurses and only 23.4 % of respondents received
diabetes support from individuals other than doctors or
nurses (family, friends, and others).Discussion
Diabetes management programs have positive effects
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Fig. 4 Types of support preferred by survey respondents. HCP, health-carethe heterogeneity of program designs and the outcomes
studied, the most effective components of diabetes
management programs are not well understood [11, 14].
This study is the first to attempt to elucidate the types of
diabetes management programs and the features of those
programs that are valued from a patient perspective. It
does so by gathering the opinions of patients with T2DM.
Recent positions of the ADA and EASD point to indi-
vidualized and tailored care [4]. As such, this investiga-
tion of the goals set by survey respondents with respect
to their own diabetes management gave valuable insights
into what the participant actually considers important.
The most frequently selected goals set by our survey
respondents were better diet (76.9 %) and weight loss
(71.4 %). Weight loss has been shown to have the most
positive effect on treatment satisfaction and quality of
life in patients with T2DM [8, 15–18]. As individuals are
more likely to adhere to treatment regimens that offer
benefits from a patient’s perspective, by including weight
loss as a major component of patient support systems,
both participation in and the effectiveness of these pro-
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Fig. 5 Sources of support preferred by survey respondents
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satisfaction with the care received from their health-care
team in the past year if they were currently participating
in a support program. This is noteworthy, and there are
multiple implications inherent in this association. Either
those who are more satisfied with their health-care team
tend to participate in programs, program participation
makes participants more cognizant/appreciative of their
HCP’s efforts, or program participation in itself leads to
better health-care and, subsequently, more satisfaction
with it on the part of patients. Compared with
nonparticipants, a patient joining a support program
may be more actively involved in his/her own care (i.e.,
increased patient engagement) and more vocal with
their provider about the care they need. This, in turn,
may allow providers to meet patients’ needs more
closely, leading to program participants being more sat-
isfied with the health-care received.
An important point emerged from the study concerning
the interaction between preferred sources and preferred24 (8.2Other
Presentations/videos
Verbal information from 
other diabetes patients




Fig. 6 Format of support most preferred by respondentsa (n = 294). aParticformats of support. Although respondents expressed the
desire for more supportive/engaged doctors and other
HCPs, and found doctors, nurses, and dietitians to be the
most preferred sources of diabetes support, there was a
clear preference for online and printed materials as sup-
port format above verbal information. This identifies an
interesting need that could potentially be addressed by
providing HCPs with useful online educational tools and
by giving them access to a library of practical printed
materials. These support formats could be used by HCPs
as a practical means to reach out to and engage with their
patients in the manner that many patients have expressed
as their preference. The findings suggest that being spe-
cifically referred to online or printed materials by their
doctors would be viewed positively and could even in-
crease the perception of doctors as being supportive
and engaged. There is a clear need for HCPs to be
aware of patients’ needs for multifaceted T2DM sup-
port, as in many cases patients are not receiving the
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the first investigation of patients’ own preferences for sup-
port in the context of diabetes management programs. The
information was obtained directly from a cross-section of
patients with T2DM in a real-world setting. Although this
study provides a snapshot of a situation at a given time, the
results present the voices of patients who are at various
points along the T2DM continuum. The study used a
mixed-methods approach, combining both qualitative and
quantitative research. The qualitative information gathered
from a small number of patients with T2DM, representing
the spectrum of patient demographics, allowed for a very
clear and directed survey to be designed to maximize the
effectiveness of the study. An additional strength of this
study was the breadth and depth of the interviews con-
ducted, which allowed the collection of a rich and
comprehensive data set that can contribute towards the
understanding of patient preferences and motivation
for management of T2DM.
While the mixed-methods approach of using the results
of a qualitative survey to design a quantitative survey was
a strength of this study, the lack of using a validated ques-
tionnaire assessing program participation and patient en-
gagement was a limitation. It should, however, be noted
that the process by which validated questionnaires are cre-
ated was operationalized in the current study: a patient
focus group was used for concept elicitation, and themes
arising from the focus group were used in the develop-
ment of survey items, domains, and response options. The
survey also included a considerable amount of ‘free-text
responses’ where patients could respond in their own
words, allowing for further thematic exploration.
Another limitation of this study was sample general-
izability. The majority of respondents were white middle-
aged, and had a higher educational level than the general
population with T2DM, which hampered our ability to
generalize these results to T2DM patients at large. There
were limited distributions of age, education, and minority
status, all potential risk factors for T2DM which lend
themselves to worse diabetes outcomes. The PLM popula-
tion is skewed towards a more female, educated, and en-
gaged group of patients, reflecting the patient population
who regularly use health-based Internet sites [19, 20]. Since
study respondents were active users of PLM, the sample
was reflective of a more highly engaged group of patients
who actively seek information, particularly online mate-
rials, and who are likely to be more proactively involved in
the management of their own condition than many other
patients with T2DM. This higher engagement is also
reflected in the mean A1C level (7.04 %) reported by the
PLM sample, which is largely considered well-controlled.
Nonetheless, respondents’ self-reported participation in
self-care management programs was low, reflecting trends
seen in other T2DM populations [21, 22]. In fact, thepercentages cited here are likely at best an underestimate of
nonparticipation in these programs in the T2DM population
as a whole. Engaged patients are most often vocal about
what does and does not work in T2DM self-management
and support programming, and are most likely to share their
hopes and goals for condition management. Learning about
program participation in an engaged population of real-
world patients allows researchers the unique opportunity to
begin to fill the gaps in what little is known about patient
preferences for and desires of T2DM care [23]. It is also ar-
guable that T2DM self-care management and programs are,
in fact, more effective when based around a group of
patients who are more engaged with their health and who
are active participants in their own care.
In the future, it will be important to investigate patient
perspectives regarding the impact of program participation
or nonparticipation. It will also be informative to understand
in greater detail the types and features of programs that gain
the attention of patients and appear to be sufficiently attract-
ive for them to take part in. Longitudinal studies could dir-
ectly follow the effects of program participation on T2DM
outcomes, such as A1C levels, weight loss, and lipid control.
Furthermore, there is a need to explore physician perspec-
tives and those of other HCPs, in addition to the preferences
of patients, because challenges facing HCPs are also import-
ant for the development of successful diabetes management
programs. Such studies, which aim to understand patient
and physician preferences for diabetes support and
management programs, will ultimately inform future re-
commendations for HCPs and could potentially result in
improvements in the overall care of patients with T2DM.
Conclusions
This study, based on a real-world sample of patients
with T2DM, revealed that the majority of patients were
not participating in any program. Among those using a
T2DM self-management program, respondents most
frequently used clinic, hospital-based, or other HCP pro-
grams. Diet and weight loss were the most important
components of diabetes management and support pro-
grams preferred by patients, followed by supportive/
engaged doctors and other HCPs.
The results of this study may help to establish a
foundation that can advise on the design of future
T2DM management support, leading to more effective
programs that will be modifiable within the context of
the individualization of care that is currently recom-
mended by the ADA and EASD.
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